1. Earnings season - Biogen, Novartis, and looking ahead to Merck — Biogen halts plans to test aducanumab — Boston Scientific ends TAVR “duopoly” -- See more on our front page news
    Plus NEW Board just launched:
    Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

DSP2 reps to be cut?

Discussion in 'Sanofi' started by anonymous, Mar 27, 2019 at 11:03 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I’ve heard this idea floated out there. Anyone know if it’s true? Would they simply eliminate one position across the board? In the past it doesn’t seem like that was how it was done....more a factor of performance and geography?
     
  2. anonymous

    anonymous Guest

    i may be wrong but i think sanofi cut an entire praluent pc sales force a couple years ago?
     
  3. anonymous

    anonymous Guest

    Yes they did , also clipped all nurse educators last year. Cut something like 15 molecules they were working on . Sanofi will do whatever they want . Just remember to not use logic as there's none with Sanofi
     
  4. anonymous

    anonymous Guest

    Yes, Whole selling teams cut in the past. Look at current call plan HO pushed out, main Soliqua writers moved to SP2. Wouldn't surprise me if PC2's are gone.
     
  5. anonymous

    anonymous Guest

    Oh please... like this company does anything in a manner that makes sense. Does anyone have any REAL insight into what and when something may or may not occur? I still think we are worrying people with just a bunch of opinions. Where’s Inside 55?
     
  6. anonymous

    anonymous Guest

    By end of Q2, RBLs and ABLs to be downsized 1st. Current ABLs only managing 6-8 reps when they should be managing 12-14. Field cuts come after.
     
  7. anonymous

    anonymous Guest

    Any truth to the Serio rumors on Wed call?
     
  8. anonymous

    anonymous Guest

    Interesting. I wonder how far in advance they announce these intentions, or will we just find out one day this summer? Sounds like no mention will be made on next week’s PC and Diabetes call.
     
  9. anonymous

    anonymous Guest

    There have been a few posts that say otherwise, some on other threads. I’m not talking opinion. There have been some that sound like inside info. I know they have to be careful what they say.
     
  10. anonymous

    anonymous Guest

    They will cut the higher paid reps, reps that are still here with pension, and those that receive a poor rating on YE.
     
  11. anonymous

    anonymous Guest

    Is this inside information from 55 or intelligent guess?
     
  12. anonymous

    anonymous Guest

    LOL, there is no 55 insider. I've been posting shit with that moniker for a long time. It really isn't that hard to predict what is happening in this division if you have been around. LMAO.
     
  13. anonymous

    anonymous Guest

    There is a 55 insider, it’s just not you!
     
  14. anonymous

    anonymous Guest

    55 insider here: Flash Sanofi to cut back R&D by 50%. A rat died.
     
  15. anonymous

    anonymous Guest

    Nope... 55 insider gave us the tell on 2/22 on different thread. Some of us caught it,little cryptic but definitely 55!
     
  16. anonymous

    anonymous Guest

    Lol, there is no 55 Insider. It was simple common sense to those that can read. Pat yourself on the back-Insider. Cryptic? Learn how to read a 10k. There is nothing cryptic about that.
     
  17. anonymous

    anonymous Guest

    Why do you think PCP 2's and not PCP 1's to be cut?
     
  18. anonymous

    anonymous Guest

    You are only a number to Sanofi, but those are not the ones that matter...its your salary. Between the pcp1/2 in your pod the higher salary is fired. Its as simple as that.
     
  19. anonymous

    anonymous Guest

    They said no cuts to SP. Why is this even coming up? You are all probably safe until next year.
     
  20. anonymous

    anonymous Guest

    SP in diabetes are on the on deck circle for end of the year and into early next year.